v3.26.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
CONSOLIDATED STATEMENTS OF OPERATIONS    
Product revenue $ 14,233,056 $ 14,481,784
License revenue 3,159,375 2,808,125
Other revenue 233,935 116,276
Revenues 17,626,366 17,406,185
Cost of sales (10,224,779) (10,305,076)
Gross profit 7,401,587 7,101,109
Operating expenses:    
Impairment loss (50,000) (43,000)
Research and development expenses (1,805,198) 0
Selling, general and administrative expenses (related party of $450,000 and $1,116,064) (8,576,702) (14,216,377)
Total operating expenses (10,431,900) (14,259,377)
Operating loss (3,030,313) (7,158,268)
Other income (expense)    
Interest expense (related party of $nil and $245,724) (13,673) (267,458)
Loss on change in fair value of profit share and unsecured note 5,926 (3,959,065)
Interest income 82,103 293,524
Total other (expense) income 74,356 (3,932,999)
Loss before provision for income taxes (2,955,957) (11,091,267)
Income tax benefit (expense) (70,050) 289,156
Net loss $ (3,026,007) $ (10,802,111)
Basic & Diluted loss per share:    
Basic and diluted net loss per share $ (0.16) $ (0.57)
Weighted average common shares outstanding:    
Basic 19,315,295 19,058,110
Diluted 19,315,295 19,058,110

Source

10-K PDF
XBRL